Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Review
Nature Reviews Cancer 5, 505–515 (1 July 2005) | doi:10.1038/nrc1647
The role of focal-adhesion kinase in cancer |[mdash]| a new therapeutic opportunity
&
Abstract
Focal-adhesion kinase (FAK) is an important mediator of growth-factor signalling, cell proliferation, cell survival and cell migration. Given that the development of malignancy is often associated with perturbations in these processes, it is not surprising that FAK activity is altered in cancer cells. Mouse models have shown that FAK is involved in tumour formation and progression, and other studies showing that FAK expression is increased in human tumours make FAK a potentially important new therapeutic target.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
